Legacy Financial Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,477
Closed -$1.61M 68
2022
Q1
$1.61M Buy
14,477
+2,953
+26% +$312K 0.68% 30
2021
Q4
$1.19M Buy
11,524
+56
+0.5% +$6.49K 0.52% 38
2021
Q3
$1.44M Buy
11,468
+720
+7% +$93.2K 0.68% 30
2021
Q2
$1.33M Buy
10,748
+665
+7% +$83.5K 0.64% 35
2021
Q1
$1.19M Buy
10,083
+422
+4% +$49.5K 0.63% 33
2020
Q4
$1.13M Buy
9,661
+123
+1% +$13.5K 0.58% 32
2020
Q3
$991K Buy
9,538
+586
+7% +$58.9K 0.57% 33
2020
Q2
$821K Buy
8,952
+453
+5% +$43.4K 0.63% 33
2020
Q1
$766K Buy
8,499
+281
+3% +$29.9K 0.73% 21
2019
Q4
$932K Buy
8,218
+583
+8% +$64K 0.75% 23
2019
Q3
$811K Buy
7,635
+398
+5% +$41.5K 0.72% 22
2019
Q2
$724K Buy
7,237
+323
+5% +$29.5K 0.68% 27
2019
Q1
$630K Buy
6,914
+372
+6% +$33.3K 0.54% 32
2018
Q4
$595K Buy
6,542
+231
+4% +$21.6K 0.59% 18
2018
Q3
$581K Buy
6,311
+981
+18% +$90.7K 0.59% 19
2018
Q2
$456K Buy
5,330
+635
+14% +$53K 0.41% 54
2018
Q1
$377K Buy
4,695
+1,654
+54% +$136K 0.37% 63
2017
Q4
$246K Buy
+3,041
New +$244K 0.26% 86

Other funds holding MDT

Legacy Financial Strategies's MDT Position: Q2 2022 in Review

Legacy Financial Strategies sold out of Medtronic (MDT) in Q2 2022, closing a stake of 14,477 shares — an estimated $1.61M sold.

Legacy Financial Strategies first reported a position in MDT in Q4 2017 and held it in 18 quarters. The position peaked at $1.61M in Q1 2022. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Legacy Financial Strategies reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Legacy Financial Strategies sold 14,477 Medtronic shares in Q2 2022, an estimated $1.61M.
  • Legacy Financial Strategies first reported a position in Medtronic in Q4 2017 and held it in 18 quarters.
  • Legacy Financial Strategies's Medtronic position peaked at $1.61M in Q1 2022.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Legacy Financial Strategies's 13F filing for Q2 2022, filed 9 Aug 2022.